Monoamine Oxidase Inhibitors (Maois) + Solriamfetol Interaction
Contraindicatedinteraction on record
Description
Do not administer SUNOSI concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment. Concomitant use may increase risk of hypertensive reaction with serious outcomes including death, stroke, myocardial infarction, and aortic dissection.
Mechanism
MAO inhibitors and noradrenergic drugs may increase the risk of a hypertensive reaction
Source: NLP:solriamfetol